Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathan Mehta

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
The American Journal of Cardiology|September 12, 2014
Impact of symptoms, gender, co-morbidities, and operator volume on outcome of carotid artery stenting (from the Nationwide Inpatient Sample [2006 to 2010])Apurva O Badheka, Ankit Chothani, Sidakpal S Panaich, et al.
The American Journal of Cardiology|December 3, 2014
Impact on in-hospital outcomes with drug-eluting stents versus bare-metal stents (from 665,804 procedures)Apurva O Badheka, Shilpkumar Arora, Sidakpal S Panaich, et al.
International Journal of Cardiology|May 6, 2014
Influence of left ventricular remodeling on atrial fibrillation recurrence and cardiovascular hospitalizations in patients undergoing rhythm-control therapyNeeraj Shah, Apurva O Badheka, Peeyush M Grover, et al.
Circulation|August 5, 2015
Response to Letter Regarding Article "Impact of Annual Operator and Institutional Volume on Percutaneous Coronary Intervention Outcomes: A 5-Year United States Experience (2005-2009)"Apurva O Badheka, Nileshkumar J Patel, Peeyush Grover, et al.
The American Journal of Medicine|March 11, 2014
Percutaneous aortic balloon valvotomy in the United States: a 13-year perspectiveApurva O Badheka, Nileshkumar J Patel, Vikas Singh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 6, 2024
Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab Plus Talazoparib in Patients With SLFN11 Positive Extensive-Stage SCLC: S1929Nagla Abdel Karim, Jieling Miao, Karen L Reckamp, et al.
Circulation. Arrhythmia and Electrophysiology|December 7, 2014
Utilization and adverse outcomes of percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation in the United States: influence of hospital volumeApurva O Badheka, Ankit Chothani, Kathan Mehta, et al.
Circulation|September 6, 2014
Impact of annual operator and institutional volume on percutaneous coronary intervention outcomes: a 5-year United States experience (2005-2009)Apurva O Badheka, Nileshkumar J Patel, Peeyush Grover, et al.
The American Journal of Medicine|May 27, 2014
Balloon mitral valvuloplasty in the United States: a 13-year perspectiveApurva O Badheka, Neeraj Shah, Abhijit Ghatak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2020
Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I-III Triple-negative Breast Cancer (NeoSTOP)Priyanka Sharma, Bruce F Kimler, Anne O'Dea, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The American Journal of Cardiology|September 12, 2014
Impact of symptoms, gender, co-morbidities, and operator volume on outcome of carotid artery stenting (from the Nationwide Inpatient Sample [2006 to 2010])Apurva O Badheka, Ankit Chothani, Sidakpal S Panaich, et al.
The American Journal of Cardiology|December 3, 2014
Impact on in-hospital outcomes with drug-eluting stents versus bare-metal stents (from 665,804 procedures)Apurva O Badheka, Shilpkumar Arora, Sidakpal S Panaich, et al.
International Journal of Cardiology|May 6, 2014
Influence of left ventricular remodeling on atrial fibrillation recurrence and cardiovascular hospitalizations in patients undergoing rhythm-control therapyNeeraj Shah, Apurva O Badheka, Peeyush M Grover, et al.
Circulation|August 5, 2015
Response to Letter Regarding Article "Impact of Annual Operator and Institutional Volume on Percutaneous Coronary Intervention Outcomes: A 5-Year United States Experience (2005-2009)"Apurva O Badheka, Nileshkumar J Patel, Peeyush Grover, et al.
The American Journal of Medicine|March 11, 2014
Percutaneous aortic balloon valvotomy in the United States: a 13-year perspectiveApurva O Badheka, Nileshkumar J Patel, Vikas Singh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 6, 2024
Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab Plus Talazoparib in Patients With SLFN11 Positive Extensive-Stage SCLC: S1929Nagla Abdel Karim, Jieling Miao, Karen L Reckamp, et al.
Circulation. Arrhythmia and Electrophysiology|December 7, 2014
Utilization and adverse outcomes of percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation in the United States: influence of hospital volumeApurva O Badheka, Ankit Chothani, Kathan Mehta, et al.
Circulation|September 6, 2014
Impact of annual operator and institutional volume on percutaneous coronary intervention outcomes: a 5-year United States experience (2005-2009)Apurva O Badheka, Nileshkumar J Patel, Peeyush Grover, et al.
The American Journal of Medicine|May 27, 2014
Balloon mitral valvuloplasty in the United States: a 13-year perspectiveApurva O Badheka, Neeraj Shah, Abhijit Ghatak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2020
Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I-III Triple-negative Breast Cancer (NeoSTOP)Priyanka Sharma, Bruce F Kimler, Anne O'Dea, et al.
Pageof 5